ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CSRT Consort Medical Plc

1,010.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Consort Medical Plc LSE:CSRT London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,010.00 1,005.00 1,010.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Consort Medical PLC Notice of Results (7108V)

07/11/2017 7:00am

UK Regulatory


Consort Medical (LSE:CSRT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Consort Medical Charts.

TIDMCSRT

RNS Number : 7108V

Consort Medical PLC

07 November 2017

Consort Medical plc

7 November 2017

Notice of Results

Consort Medical plc ("Consort Medical", "Consort") (LSE: CSRT), a leading, global, single source pharma services drug and delivery device company, will announce its interim results for the six months ended 31 October 2017 on Tuesday, 5 December 2017.

ENDS

Enquiries:

 
 Consort Medical   Tel: +44 1442 867 920 
 

Jonathan Glenn - Chief Executive Officer

Paul Hayes - Chief Financial Officer

 
 FTI Consulting   Tel: +44 20 3727 1000 
 

Ben Atwell / Simon Conway

Consort Medical plc is a leading, global, single source drug and delivery device company (CDMO). We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectable products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.

We employ c.2,000 people globally of which c.1,400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBRBDBBGGBGRL

(END) Dow Jones Newswires

November 07, 2017 02:00 ET (07:00 GMT)

1 Year Consort Medical Chart

1 Year Consort Medical Chart

1 Month Consort Medical Chart

1 Month Consort Medical Chart

Your Recent History

Delayed Upgrade Clock